Plasma Exchange and Retransplantation in Recurrent Nephrosis of Patients With Congenital Nephrotic Syndrome of the Finnish Type (NPHS1)
Authors:
- Arvi-Matti KuusniemiAKArvi-Matti Kuusniemi
- Erik QvistEQErik Qvist
- Yi SunYSYi Sun
- Jaakko PatrakkaJPJaakko Patrakka
- Kai RönnholmKRKai Rönnholm
- Riitta KarikoskiRKRiitta Karikoski
- Hannu JalankoHJHannu Jalanko
- 27 May 2007
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 83 (10) , 1316-1323
Abstract
Recurrent nephrotic syndrome (NS) is a severe problem after renal transplantation in patients with congenital nephrotic syndrome of the Finnish type (NPHS1). The NPHS1 kidneys do not express nephrin, and antibodies against this major glomerular filter protein have been observed in NPHS1 children with recurrent NS. We evaluated here the use of plasma exchange (PE) therapy and kidney retransplantation in NPHS1 patients with recurrent NS and extended our studies on the pathogenesis of the recurrence. Clinical data on 65 NPHS1 patients who received 77 kidney transplants between the years 1986 and 2006 was collected. Serum anti-nephrin antibodies were assayed with an enzyme-linked immunosorbent assay method, and the kidney biopsy samples were evaluated by light microscopy and immunohistochemistry. Twenty-three episodes of recurrent NS occurred in 19 grafts of 13 NPSH1 patients homozygous for Fin-major mutation. Six retransplantations were performed to four NPHS1 patients, who lost their graft because of recurrent NS, and heavy proteinuria developed immediately in all cases. Although 73% of the patients had detectable serum anti-nephrin antibodies, the kidney biopsy findings were minimal. Introduction of PE alongside cyclophosphamide proved effective in the treatment of the proteinuric episodes (one graft loss out of nine). If remission was achieved, recurrent NS did not significantly deteriorate the long term graft function. The clinical and pathological data suggest that anti-nephrin antibodies effectively impair the glomerular function in kidney grafts of NPHS1 patients homozygous for Fin-major mutation. Plasma exchange is a useful adjunct to the treatment of the recurrent NS.Keywords
This publication has 21 references indexed in Scilit:
- Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1)Kidney International, 2006
- Organ Exchanges: Fairness to the O-Blood GroupAmerican Journal of Transplantation, 2006
- NPHS2 mutation associated with recurrence of proteinuria after transplantationPediatric Nephrology, 2004
- RECURRENCE OF NEPHROTIC SYNDROME IN KIDNEY GRAFTS OF PATIENTS WITH CONGENITAL NEPHROTIC SYNDROME OF THE FINNISH TYPETransplantation, 2002
- Long-term follow up of renal function and histology after renal allograft transplantation in early childhoodTransplant International, 1998
- Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic SyndromeMolecular Cell, 1998
- Divalency of the monoclonal antibody 5-1-6 is required for induction of proteinuria in ratsClinical and Experimental Immunology, 1993
- Quantitative studies of monoclonal antibody 5-1-6-induced proteinuric state in ratsClinical and Experimental Immunology, 1992
- Histopathological findings in well-functioning, long-term renal allograftsKidney International, 1992
- IMMUNOSUPPRESSION AND PLASMA-EXCHANGE IN THE TREATMENT OF GOODPASTURE'S SYNDROMEThe Lancet, 1976